{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:35Z","timestamp":1787020655285,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-03005-y","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:03:08Z","timestamp":1764169388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neutrophil cathepsin G and risk of cardiovascular events in patients with diabetes mellitus"],"prefix":"10.1186","volume":"24","clinical-trial-number":[{"clinical-trial-number":"nct01882114","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04036357","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Francesco","family":"Baratta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bartimoccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Cocomello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Cammisotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Nocella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"34","key":"3005_CR1","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337.","journal-title":"Eur Heart J"},{"issue":"2","key":"3005_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255\u2013323.","journal-title":"Eur Heart J"},{"issue":"3","key":"3005_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","volume":"16","author":"PEJ van der Meijden","year":"2019","unstructured":"van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16(3):166\u201379.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"3005_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2174\/1381612043453144","volume":"10","author":"FA Fitzpatrick","year":"2004","unstructured":"Fitzpatrick FA. Cyclooxygenase enzymes: regulation and function. Curr Pharm Des. 2004;10(6):577\u201388.","journal-title":"Curr Pharm Des"},{"issue":"5\u20136","key":"3005_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","volume":"110","author":"JR Vane","year":"2003","unstructured":"Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110(5\u20136):255\u20138.","journal-title":"Thromb Res"},{"issue":"3","key":"3005_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","volume":"321","author":"SL Zheng","year":"2019","unstructured":"Zheng SL, Roddick AJ. Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA. 2019;321(3):277\u201387.","journal-title":"JAMA"},{"issue":"11","key":"3005_CR7","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","volume":"118","author":"MS Shah","year":"2016","unstructured":"Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res. 2016;118(11):1808\u201329.","journal-title":"Circ Res"},{"issue":"10","key":"3005_CR8","doi-asserted-by":"publisher","first-page":"e396","DOI":"10.1161\/ATVBAHA.123.319522","volume":"43","author":"R Carnevale","year":"2023","unstructured":"Carnevale R, Leopizzi M, Dominici M, d\u2019Amati G, Bartimoccia S, Nocella C, et al. PAD4-induced netosis via cathepsin G-mediated platelet-neutrophil interaction in ChAdOx1 vaccine-induced thrombosis-brief report. Arterioscler Thromb Vasc Biol. 2023;43(10):e396\u2013403.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"33","key":"3005_CR9","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1093\/eurheartj\/ehz893","volume":"41","author":"R Carnevale","year":"2020","unstructured":"Carnevale R, Sciarretta S, Valenti V, di Nonno F, Calvieri C, Nocella C, et al. Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction. Eur Heart J. 2020;41(33):3156\u201365.","journal-title":"Eur Heart J"},{"issue":"10","key":"3005_CR10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.amjcard.2015.02.032","volume":"115","author":"D Pastori","year":"2015","unstructured":"Pastori D, Loffredo L, Perri L, Baratta F, Scardella L, Polimeni L, et al. Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors. Am J Cardiol. 2015;115(10):1402\u20136.","journal-title":"Am J Cardiol"},{"key":"3005_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9040296","author":"V Cammisotto","year":"2020","unstructured":"Cammisotto V, Pastori D, Nocella C, Bartimoccia S, Castellani V, Marchese C, et al. PCSK9 regulates Nox2-mediated platelet activation via CD36 receptor in patients with atrial fibrillation. Antioxidants. 2020. https:\/\/doi.org\/10.3390\/antiox9040296.","journal-title":"Antioxidants"},{"issue":"Supplement_1","key":"3005_CR12","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"ADAPP Committee","year":"2025","unstructured":"ADAPP Committee. 2\u2014Diagnosis and classification of diabetes: standards of care in diabetes-2025. Diabetes Care. 2025;48(Supplement_1):S27\u201349.","journal-title":"Diabetes Care"},{"issue":"1","key":"3005_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12933-024-02263-6","volume":"23","author":"A Colantoni","year":"2024","unstructured":"Colantoni A, Bucci T, Cocomello N, Angelico F, Ettorre E, Pastori D, et al. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):175.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3005_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.gheart.2018.08.004","volume":"13","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. for the universal definition of myocardial infarction EGobotJESoCEACoCAAHAAWHFWTF: fourth universal definition of myocardial infarction (2018). Glob Heart. 2018;13(4):305\u201338.","journal-title":"Glob Heart"},{"issue":"7","key":"3005_CR15","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44(7):2064\u201389.","journal-title":"Stroke"},{"key":"3005_CR16","doi-asserted-by":"crossref","unstructured":"Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21(4):637\u2013676.","DOI":"10.1161\/01.STR.21.4.637"},{"issue":"47","key":"3005_CR17","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1093\/eurheartj\/ehad649","volume":"44","author":"J Luo","year":"2023","unstructured":"Luo J, Thomassen JQ, Nordestgaard BG, Tybj\u00e6rg-Hansen A, Frikke-Schmidt R. Neutrophil counts and cardiovascular disease. Eur Heart J. 2023;44(47):4953\u201364.","journal-title":"Eur Heart J"},{"issue":"6","key":"3005_CR18","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/ATVBAHA.118.310945","volume":"38","author":"C Welsh","year":"2018","unstructured":"Welsh C, Welsh P, Mark PB, Celis-Morales CA, Lewsey J, Gray SR, et al. Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK Biobank. Arterioscler Thromb Vasc Biol. 2018;38(6):1415\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3005_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081907","author":"R Xie","year":"2024","unstructured":"Xie R, Bishai DM, Lui DTW, Lee PCH, Yap DYH. Higher circulating neutrophil counts is associated with increased risk of all-cause mortality and cardiovascular disease in patients with diabetic kidney disease. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12081907.","journal-title":"Biomedicines"},{"issue":"2","key":"3005_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0741-5214(94)70106-7","volume":"19","author":"CA LaRosa","year":"1994","unstructured":"LaRosa CA, Rohrer MJ, Benoit SE, Rodino LJ, Barnard MR, Michelson AD. Human neutrophil cathepsin G is a potent platelet activator. J Vasc Surg. 1994;19(2):306\u201318.","journal-title":"J Vasc Surg"},{"issue":"10","key":"3005_CR21","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1074\/jbc.275.10.6819","volume":"275","author":"GR Sambrano","year":"2000","unstructured":"Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem. 2000;275(10):6819\u201323.","journal-title":"J Biol Chem"},{"issue":"1","key":"3005_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12964-018-0235-0","volume":"16","author":"O Elaskalani","year":"2018","unstructured":"Elaskalani O, Abdol Razak NB, Metharom P. Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones. Cell Commun Signal. 2018;16(1):24.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"3005_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071447","volume":"8","author":"N Faraday","year":"2013","unstructured":"Faraday N, Schunke K, Saleem S, Fu J, Wang B, Zhang J, et al. Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils. PLoS ONE. 2013;8(8):e71447.","journal-title":"PLoS ONE"},{"issue":"2","key":"3005_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1161\/CIRCRESAHA.124.324649","volume":"135","author":"F Violi","year":"2024","unstructured":"Violi F, Bartimoccia S, Cangemi R, Nocella C, D\u2019Amico A, Oliva A, et al. Neutrophil Cathepsin G and thrombosis in COVID-19. Circ Res. 2024;135(2):350\u20132.","journal-title":"Circ Res"},{"key":"3005_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106098","volume":"141","author":"WC Keeter","year":"2021","unstructured":"Keeter WC, Moriarty AK, Galkina EV. Role of neutrophils in type 2 diabetes and associated atherosclerosis. Int J Biochem Cell Biol. 2021;141:106098.","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"3005_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41569-019-0326-7","volume":"17","author":"C Silvestre-Roig","year":"2020","unstructured":"Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020;17(6):327\u201340.","journal-title":"Nat Rev Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-03005-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:03:10Z","timestamp":1764169390000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-03005-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3005"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-03005-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocols received approval from the local Ethics Committee of Sapienza University of Rome (Approval Numbers 1306\/2007 and 2277\/2011).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"448"}}